Clinical Trial Update: Carvedilol + Simvastatin vs. Carvedilol Alone for Cirrhosis and Cirrhotic Cardiomyopathy and Impact on Hepatic Decompensation and Survival [NA]

View source ↗

Summary

This clinical trial evaluates whether adding simvastatin to carvedilol improves hepatic decompensation and survival in patients with decompensated cirrhosis and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis of the Liver
• Cirrhotic Cardiomyopathy
• Decompensated Cirrhosis
• Kidney Injury
• Left Ventricular Diastolic Dysfunction

Drugs mentioned

• CARVEDILOL (Carvedilol)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Decompensated Cirrhosis, Cirrhotic Cardiomyopathy | NA | Status: RECRUITING